位于861位的NLRP3LRR域中的致病变体对一个依赖增强的非典型CAPS表型负责
Antoine Fayand1, Margaux Cescato2, Laurent Le Corre2
1Department of Internal Medicine, National Reference Center for Autoinflammatory Diseases and Amyloid A Amyloidosis, Tenon Hospital, Sorbonne Université, Paris, France; Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique, Université Paris Cité, Paris, France.
The Journal of allergy and clinical immunology
|July 28, 2023
概括
与冷素相关周期性综合征 (CAPS) 相关的NLRP3基因 (NLRP3) 的致病变体可以导致异常症状,包括听力损失而不是典型的皮疹. 这些变异导致IL-1β分泌量增加,这取决于激活信号.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 低氨酸相关周期性综合征 (CAPS) 通常与NACHT域中的NLRP3基因变异有关.
- 感冒引起的疹疹是CAPS的常见临床特征.
- 本研究重点关注LRR域中的NLRP3变体,特别是Y861.
研究的目的:
- 调查CAPS患者的基因型/表型相关性.
- 探索NLRP3中Y861置换对细胞水平NLRP3激活的影响.
主要方法:
- 将14名具有NLRP3 Y861替代物的CAPS患者的临床特征与48名具有LRR域外变异的CAPS患者进行比较.
- 在刺激后,评估了来自患者和健康捐赠者的外周血液单核细胞 (PBMC) 和单细胞的IL-1β分泌.
主要成果:
- 替代NLRP3 Y861与感官神经听力损失的更高患病率和较少的皮肤疹有关.
- 与健康对照人群相比,来自Y861变异患者的细胞显示了依赖于刺激的IL-1β过分分泌.
结论:
- 在NLRP3 Y861的致病变体与非典型的CAPS表型有关.
- 这些变异驱动了依赖于刺激的IL-1β的过分分泌,影响了疾病的呈现.
相关概念视频
Cystic Fibrosis: Pathogenesis
290
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
290
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Antigen Processing Pathways
1.1K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.1K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Antigens Involved in Adaptive Immunity
544
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
544
Viral Mutations
32.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K


